AKT1 and Cognitive impairment: Calycosin alleviated diabetes mellitus-induced renal inflammation and cognitive impairment by regulating the NF-κB pathway [41] and reducing oxidative stress-mediated PI3K/Akt/GSK-3β signaling [42], respectively.